Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinoma

International Journal of Cancer

Volumn 86, Issue 2, 2000, Pages 244-250

  Sung, Nancy S ^a   Zeng, Yi ^c   Raab Traub, Nancy ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELISM; ARTICLE; CHINA; CHROMOSOME 3P; EPSTEIN BARR VIRUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS TRANSFORMATION;

ACID ANHYDRIDE HYDROLASES; ALLELES; CHINA; CHROMOSOMES, HUMAN, PAIR 3; ENDEMIC DISEASES; EPSTEIN-BARR VIRUS INFECTIONS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; PROTEINS;

EID: 0034074404     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000415)86:2<244::AID-IJC14>3.0.CO;2-V     Document Type: Article

References (33)

1. ABDEL-HAMID, M., CHEN, J.J., CONSTANTTNE, N., MASSOUD, M. and RAABTRAUB, N., EBV strain variation: geographical distribution and relation to disease state. Virology, 190, 168-175 (1992).
2. BARNES, L.D., GARRISON, P.N., SIPRASHVILI, Z., GURANOWSKI, A., ROBINSON, A.K., INGRAM, S.W., CROCE, C.M., OHTA, M. and HUEBNER, K., FHIT, a putative tumor suppressor in humans, is a dinucleoside 5′,5‴-P1,P3-triphosphate hydrolase. Biochemistry, 35, 11529-11535 (1996).
3. BOLDOG, F.L., GEMMILL, R.M., WILKE, C.M., GLOVER, T.W., NILSSON, A.S., CHANDRASEKHARAPPA, S.C., BROWN, R.S., LI, F.P. and DRABKIN, H.A., Positional cloning of the hereditary renal carcinoma 3:8 chromosome translocation breakpoint. Proc. nat. Acad. Sci. (Wash.), 90, 8509-8513 (1993).
4. CHENG, Y., POULOS, N.E., LUNG, M.L., HAMPTON, G., OU, B., LERMAN, M.I. and STANBRIDGE, E.J., Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc. nat. Acad. Sci. (Wash.), 95, 3042-7 (1998).
5. CHIA, K. and LEE, H., In: V. Chong and S. Tsao (eds.), Nasopharyngeal carcinoma, p. 2. Loi Printing, Singapore (1997).
6. CHOI, P.H., SUEN, M.W., HUANG, D.P., LO, K.W. and LEE, J.C., Nasopharyngeal carcinoma: genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients. Cancer, 72, 2873-2878 (1993).
7. DATTA, A., FEIGHNY, R. and PAGANO, J., Induction of Epstein-Barr virus associated DNA polymerase by 12-O-tetradecanoylphorbol-13-acetate: purification and characterization. J. biol. Chem., 255, 5120-5125 (1980).
8. DRUCK, T. and 15 OTHERS, Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57, 504-512 (1997).
9. EFFERT, P., MCCOY, R., ABDEL-HAMID, M., FLYNN, K., ZHANG, Q., BUSSON, P., TURSZ, T., LIU, E. and RAAB-TRAUB, N., Alterations of the p53 gene in nasopharyngeal carcinoma. J. Virol., 66, 3768-3775 (1992).
10. FONG, K.M. and 12 OTHERS, FHlT and FRA3B 3pl4.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res., 57, 2256-2267 (1997).
11. GYAPAY, G., MORISETTE, J., DIB, C., FIZAMES, C., MILLASSEAU, P., MARC, S., BERNADI, G., LATHROP, M. and WEISSEMBACH, J., The 1993-93 Genethon human genetic linkage map. Nature (Genet.), 7, 246-339 (1994).
12. HENLE, G. and HENLE, W., Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer, 17, 1-17 (1979).
13. HU, L.F., EIRIKSDOTTIR, G., LEBEDEVA, T., KHOLODNIOUK, I., ALIMOV, A., CHEN, F., LUO, Y., ZABAROVSKY, E.R., INGVARSSON, S., KLEIN, G. and ERNBERG, I., Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma. Genes Chromosomes Cancer, 17, 118-126 (1996).
14. HU, M.X., Epidemiology of nasopharyngeal carcinoma. In: Y. Zeng and B.X. Ou (eds.), Etiology and pathogenesis of nasopharyngeal carcinoma, pp. 1-17, The People's Medical Publishing House, Beijing (1992).
15. HUANG, D.P., HO, J.H., CHAN, W.K., LAU, W.H. and LUI, M., Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese. Int. J. Cancer, 43, 936-939 (1989).
16. HUANG, D.P., LO, K.W., CHOI, P.H., NG, A.Y., TSAO, S.Y., YIU, G.K. and LEE, J.C., Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet. Cytogenet., 54, 91-99 (1991).
17. HUANG, D.P., LO, K.W., VAN HASSELT, C.A., WOO, J.K., CHOI, P.H., LEUNG, S.F., CHEUNG, S.T., CAIRNS, P., SIDRANSKY, D. and LEE, J.C., A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res., 54, 4003-4006 (1994).
18. HUI, A.B., LO, K.W., LEUNG, S.F., CHOI, P.H., FONG, Y., LEE, J.C. and HUANG, D.P., Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res., 56, 3225-3229 (1996).
19. LO, K., TSAO, S., LEUNG, S., CHOI, P., LEE, J. and HUANG, D., Detailed deletion mapping on the short arm of chromosome 3 in nasopharyngeal carcinoma. Int. J. Oncol., 4, 1359-1364 (1994).
20. LU, S.J., DAY, N.E., DEGOS, L., LEPAGE, V., WANG, P.C., CHAN, S.H., SIMONS, M., MCKNIGHT, B., EASTON, D., ZENG, Y. and DE THÉ, G., Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature (Lond.), 346, 470-471 (1990).
21. LUX, A., BARDENHEUER, W., MICHAEL, D., BROCKER, F., JULICHER, K., VIETEN, L., MICHAELIS, S., SEEBER, S., OPALKA, B. and SCHUTTE, J., Identification of novel 'expressed sequence tags' within the FHIT gene locus in human chromosome region 3p14.2. Hum. Genet., 100, 90-95 (1997).
22. MAO, L., FAN, Y.H., LOTAN, R. and HONG, W.K., Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res., 56, 5128-5131 (1996).
23. NEUBAUER, A., NEUBAUER, B. and LIU, E., Polymerase chain reaction-based assay to detect allelic loss in human DNA: loss of β-interferon gene in chronic myelogenous leukemia. Nucleic Acids Res., 18, 993-998 (1990).
24. OHTA, M., INOUE, H., COTTICELLI, M.G., KASTURY, K., BAFFA, R., PALAZZO, J., SIPRASHVILI, Z., MORI, M., MCCUE, P., DRUCK, T., CROCE, C.M. and HUEBNER, K., The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84, 587-597 (1996).
25. PANAGOPOULOS, I., THELIN, S., MERTENS, F., MITELMAN, F. and AMAN, P., Variable FHIT transcripts in non-neoplastic tissues. Genes Chromosomes Cancer, 19, 215-219 (1997).
26. RAAB-TRAUB, N. and FLYNN, K., The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell, 47, 883-889 (1986).
27. RAAB-TRAUB, N., FLYNN, K., PEARSON, G., HUANG, A., LEVINE, P., LANIER, A. and PAGANO, J., The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int. J. Cancer, 39, 25-29 (1987).
28. SIXBEY, J.W. and YAO, Q.Y., Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science, 255, 1578-1580 (1992).
29. SOZZI, G. and 13 OTHERS, The FHIT gene 3p14.2 is abnormal in lung cancer. Cell, 85, 17-26 (1996).
30. SUNG, N.S., EDWARDS, R., SEILLIER-MOISEIWITSCH, F., PERKINS, A., ZENG, A. and RAAB-TRAUB, N., Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and nonendemic regions of China. Int. J. Cancer, 76, 207-215 (1998).
31. WILLIAMS, E.H. and DE THÉ, G., Letter: Familial aggregation in nasopharyngeal carcinoma. Lancet, 2, 295-296 (1974).
32. YU, M., HO, J., LAI, S. and HENDERSON, B., Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res., 46, 956-961 (1986).
33. ZENG, Y., ZHANG, L.G., LI, H.Y., JAN, M.G., ZHANG, Q., WU, Y.C., WANG, Y.S. and SU, G.R., Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int. J. Cancer, 29, 139-141 (1982).